Novo Nordisk AS
A3EU6F
DK0062498333 //
Quelle: CPH Equities: 12:23:26
279,75 DKK
Kurs
Kurs
-0,23%
Diff. Vortag in %
Diff. Vortag in %
224,25 DKK
52 Wochen Tief
52 Wochen Tief
409,95 DKK
52 Wochen Hoch
52 Wochen Hoch
- Neutral
- Seit dem 07.07.2026
- Informationen von thescreener.com
Tools
Fundamentalanalyse
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 12 Monate | 12 Monate | 279,75 265 | 279,75 | 265 | 5,272565 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.09.2026 12 Monate | 11.09.2026 | 12 Monate | 279,75 250 | 279,75 | 250 | 10,634495 | MORGAN STANLEY | ||
| Novo Nordisk AS | 07.09.2026 12 Monate | 07.09.2026 | 12 Monate | 279,75 300 | 279,75 | 300 | 7,238606 | BARCLAYS | ||
| Novo Nordisk AS | 03.09.2026 0 Monate | 03.09.2026 | 0 Monate | 279,75 275 | 279,75 | 275 | 1,697945 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 279,75 265 | 279,75 | 265 | 5,272565 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 279,75 265 | 279,75 | 265 | 5,272565 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 12 Monate | 12 Monate | 279,75 290 | 279,75 | 290 | 3,663986 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 24.08.2026 0 Monate | 24.08.2026 | 0 Monate | 279,75 275 | 279,75 | 275 | 1,697945 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 279,75 290 | 279,75 | 290 | 3,663986 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.08.2026 0 Monate | 11.08.2026 | 0 Monate | 279,75 305 | 279,75 | 305 | 9,025916 | BERENBERG | ||
| Novo Nordisk AS | 07.08.2026 0 Monate | 07.08.2026 | 0 Monate | 279,75 | 279,75 | -- | DZ BANK | |||
| Novo Nordisk AS | 06.08.2026 12 Monate | 06.08.2026 | 12 Monate | 279,75 285 | 279,75 | 285 | 1,876676 | GOLDMAN SACHS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 06.08.2026 12 Monate | 06.08.2026 | 12 Monate | 279,75 290 | 279,75 | 290 | 3,663986 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 05.08.2026 0 Monate | 05.08.2026 | 0 Monate | 279,75 200 | 279,75 | 200 | 28,507596 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 05.08.2026 0 Monate | 05.08.2026 | 0 Monate | 279,75 332 | 279,75 | 332 | 18,677391 | UBS | ||
| Novo Nordisk AS | 05.08.2026 12 Monate | 05.08.2026 | 12 Monate | 279,75 310 | 279,75 | 310 | 10,813226 | BARCLAYS | ||
| Novo Nordisk AS | 04.08.2026 12 Monate | 04.08.2026 | 12 Monate | 279,75 285 | 279,75 | 285 | 1,876676 | JEFFERIES | ||
| Novo Nordisk AS | 04.08.2026 0 Monate | 04.08.2026 | 0 Monate | 279,75 332 | 279,75 | 332 | 18,677391 | UBS | ||
| Novo Nordisk AS | 31.07.2026 0 Monate | 31.07.2026 | 0 Monate | 279,75 250 | 279,75 | 250 | 10,634495 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 279,75 290 | 279,75 | 290 | 3,663986 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 10.07.2026 0 Monate | 10.07.2026 | 0 Monate | 279,75 332 | 279,75 | 332 | 18,677391 | UBS | ||
| Novo Nordisk AS | 29.06.2026 12 Monate | 29.06.2026 | 12 Monate | 279,75 285 | 279,75 | 285 | 1,876676 | JEFFERIES | ||
| Novo Nordisk AS | 28.06.2026 0 Monate | 28.06.2026 | 0 Monate | 279,75 250 | 279,75 | 250 | 10,634495 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 279,75 290 | 279,75 | 290 | 3,663986 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 16.06.2026 0 Monate | 16.06.2026 | 0 Monate | 279,75 325 | 279,75 | 325 | 16,175156 | BERENBERG | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 279,75 290 | 279,75 | 290 | 3,663986 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 279,75 250 | 279,75 | 250 | 10,634495 | JPMORGAN | ||
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 279,75 250 | 279,75 | 250 | 10,634495 | JPMORGAN | ||
| Novo Nordisk AS | 03.06.2026 12 Monate | 03.06.2026 | 12 Monate | 279,75 305 | 279,75 | 305 | 9,025916 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 29.05.2026 0 Monate | 29.05.2026 | 0 Monate | 279,75 270 | 279,75 | 270 | 3,485255 | JEFFERIES | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 279,75 290 | 279,75 | 290 | 3,663986 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 279,75 290 | 279,75 | 290 | 3,663986 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 18.05.2026 0 Monate | 18.05.2026 | 0 Monate | 279,75 300 | 279,75 | 300 | 7,238606 | BARCLAYS | ||
| Novo Nordisk AS | 12.05.2026 12 Monate | 12.05.2026 | 12 Monate | 279,75 270 | 279,75 | 270 | 3,485255 | JEFFERIES | ||
| Novo Nordisk AS | 11.05.2026 12 Monate | 11.05.2026 | 12 Monate | 279,75 175 | 279,75 | 175 | 37,444147 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 279,75 290 | 279,75 | 290 | 3,663986 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 0 Monate | 0 Monate | 279,75 290 | 279,75 | 290 | 3,663986 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 279,75 | 279,75 | -- | DZ BANK | |||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 279,75 300 | 279,75 | 300 | 7,238606 | BARCLAYS | ||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 279,75 332 | 279,75 | 332 | 18,677391 | UBS | ||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 279,75 250 | 279,75 | 250 | 10,634495 | JPMORGAN | ||
| Novo Nordisk AS | 06.05.2026 12 Monate | 06.05.2026 | 12 Monate | 279,75 263 | 279,75 | 263 | 5,987489 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 279,75 250 | 279,75 | 250 | 10,634495 | JPMORGAN | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 279,75 175 | 279,75 | 175 | 37,444147 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 279,75 300 | 279,75 | 300 | 7,238606 | BARCLAYS | ||
| Novo Nordisk AS | 29.04.2026 12 Monate | 29.04.2026 | 12 Monate | 279,75 250 | 279,75 | 250 | 10,634495 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 279,75 275 | 279,75 | 275 | 1,697945 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 279,75 270 | 279,75 | 270 | 3,485255 | JEFFERIES |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 279,75 250 | 279,75 | 250 | 10,634495 | JPMORGAN | ||
| Novo Nordisk AS | 15.04.2026 12 Monate | 15.04.2026 | 12 Monate | 279,75 270 | 279,75 | 270 | 3,485255 | JEFFERIES | ||
| Novo Nordisk AS | 09.04.2026 0 Monate | 09.04.2026 | 0 Monate | 279,75 332 | 279,75 | 332 | 18,677391 | UBS | ||
| Novo Nordisk AS | 01.04.2026 0 Monate | 01.04.2026 | 0 Monate | 279,75 270 | 279,75 | 270 | 3,485255 | BARCLAYS | ||
| Novo Nordisk AS | 31.03.2026 12 Monate | 31.03.2026 | 12 Monate | 279,75 263 | 279,75 | 263 | 5,987489 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 30.03.2026 0 Monate | 30.03.2026 | 0 Monate | 279,75 270 | 279,75 | 270 | 3,485255 | BARCLAYS | ||
| Novo Nordisk AS | 29.03.2026 0 Monate | 29.03.2026 | 0 Monate | 279,75 250 | 279,75 | 250 | 10,634495 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 279,75 275 | 279,75 | 275 | 1,697945 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.03.2026 0 Monate | 26.03.2026 | 0 Monate | 279,75 270 | 279,75 | 270 | 3,485255 | BARCLAYS | ||
| Novo Nordisk AS | 25.03.2026 0 Monate | 25.03.2026 | 0 Monate | 279,75 250 | 279,75 | 250 | 10,634495 | JPMORGAN | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 279,75 270 | 279,75 | 270 | 3,485255 | JEFFERIES | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 279,75 270 | 279,75 | 270 | 3,485255 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 11.03.2026 0 Monate | 11.03.2026 | 0 Monate | 279,75 300 | 279,75 | 300 | 7,238606 | BERENBERG | ||
| Novo Nordisk AS | 09.03.2026 0 Monate | 09.03.2026 | 0 Monate | 279,75 250 | 279,75 | 250 | 10,634495 | JPMORGAN | ||
| Novo Nordisk AS | 06.03.2026 12 Monate | 06.03.2026 | 12 Monate | 279,75 270 | 279,75 | 270 | 3,485255 | BARCLAYS | ||
| Novo Nordisk AS | 02.03.2026 12 Monate | 02.03.2026 | 12 Monate | 279,75 260 | 279,75 | 260 | 7,059875 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 02.03.2026 0 Monate | 02.03.2026 | 0 Monate | 279,75 270 | 279,75 | 270 | 3,485255 | BARCLAYS | ||
| Novo Nordisk AS | 27.02.2026 12 Monate | 27.02.2026 | 12 Monate | 279,75 270 | 279,75 | 270 | 3,485255 | BARCLAYS | ||
| Novo Nordisk AS | 24.02.2026 12 Monate | 24.02.2026 | 12 Monate | 279,75 400 | 279,75 | 400 | 42,984808 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.02.2026 0 Monate | 24.02.2026 | 0 Monate | 279,75 250 | 279,75 | 250 | 10,634495 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 279,75 400 | 279,75 | 400 | 42,984808 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 279,75 332 | 279,75 | 332 | 18,677391 | UBS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 279,75 340 | 279,75 | 340 | 21,537087 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 279,75 275 | 279,75 | 275 | 1,697945 | JEFFERIES |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 279,75 350 | 279,75 | 350 | 25,111707 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 279,75 340 | 279,75 | 340 | 21,537087 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 279,75 275 | 279,75 | 275 | 1,697945 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 279,75 250 | 279,75 | 250 | 10,634495 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 279,75 270 | 279,75 | 270 | 3,485255 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 279,75 340 | 279,75 | 340 | 21,537087 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 279,75 340 | 279,75 | 340 | 21,537087 | BARCLAYS | ||
| Novo Nordisk AS | 17.02.2026 0 Monate | 17.02.2026 | 0 Monate | 279,75 340 | 279,75 | 340 | 21,537087 | BARCLAYS | ||
| Novo Nordisk AS | 12.02.2026 0 Monate | 12.02.2026 | 0 Monate | 279,75 340 | 279,75 | 340 | 21,537087 | BARCLAYS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 279,75 400 | 279,75 | 400 | 42,984808 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 279,75 275 | 279,75 | 275 | 1,697945 | JEFFERIES | ||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 279,75 360 | 279,75 | 360 | 28,686327 | BERENBERG |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 279,75 360 | 279,75 | 360 | 28,686327 | BARCLAYS | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 279,75 360 | 279,75 | 360 | 28,686327 | BARCLAYS | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 279,75 350 | 279,75 | 350 | 25,111707 | JPMORGAN | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 279,75 332 | 279,75 | 332 | 18,677391 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 279,75 475 | 279,75 | 475 | 69,794459 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 279,75 332 | 279,75 | 332 | 18,677391 | UBS | ||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 279,75 350 | 279,75 | 350 | 25,111707 | JPMORGAN | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 279,75 270 | 279,75 | 270 | 3,485255 | JEFFERIES | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 279,75 350 | 279,75 | 350 | 25,111707 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 279,75 350 | 279,75 | 350 | 25,111707 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 279,75 360 | 279,75 | 360 | 28,686327 | BARCLAYS | ||
| Novo Nordisk AS | 01.02.2026 0 Monate | 01.02.2026 | 0 Monate | 279,75 390 | 279,75 | 390 | 39,410188 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 29.01.2026 0 Monate | 29.01.2026 | 0 Monate | 279,75 350 | 279,75 | 350 | 25,111707 | JPMORGAN | ||
| Novo Nordisk AS | 23.01.2026 12 Monate | 23.01.2026 | 12 Monate | 279,75 270 | 279,75 | 270 | 3,485255 | JEFFERIES | ||
| Novo Nordisk AS | 22.01.2026 12 Monate | 22.01.2026 | 12 Monate | 279,75 436 | 279,75 | 436 | 55,853441 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 22.01.2026 0 Monate | 22.01.2026 | 0 Monate | 279,75 415 | 279,75 | 415 | 48,346738 | BERENBERG |
News
Aktuell
| Datum | Terminart Information | Information |
|---|---|---|
| 04.11.2026 | Bericht zum 3. Quartal Novo Nordisk A/S: Third quarter 2026 | Novo Nordisk A/S: Third quarter 2026 |
Anlage-Spezial Europäische Aktien
28.05.2026
Novo Nordisk: KI und Amycretin zünden nächste Pipeline-Stufe
KI beschleunigt die Wirkstoffforschung von Novo Nordisk erheblich. Neue Tabletten wie Amycretin sichern dabei die künftige Marktdominanz ab.
DZ BANK Produktauswahl
Optionsscheine Classic Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
Abstand zum Basispreis in %
Max
Discount Classic
Produktauswahl : Basiswert Novo Nordisk AS
Min
Discount in %
Max
Endlos Turbos Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Optionsscheine Classic Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
Abstand zum Basispreis in %
Max
Endlos Turbos Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Knock Out Map
- wertpapiere@dzbank.de (069) 7447-7035
-
DZ BANK AG, Platz der Republik,
60265 Frankfurt / M